Comment on "In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2".
作者信息
Gharebaghi Reza, Heidary Fatemeh
机构信息
International Virtual Ophthalmic Research Center, Austin, TX, USA.
出版信息
Iran J Public Health. 2022 May;51(5):1198-1199. doi: 10.18502/ijph.v51i5.9443.
Abstract
摘要
相似文献
1
Comment on "In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2".关于“ACE2的SARS-CoV-2结合位点潜在抑制剂的单独或联合效应的计算机模拟比较”的评论
Iran J Public Health. 2022 May;51(5):1198-1199. doi: 10.18502/ijph.v51i5.9443.
2
Response Comment on "In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2".对《ACE2的SARS-CoV-2结合位点潜在抑制剂的单独或联合效应的计算机模拟比较》的回应评论
Iran J Public Health. 2022 May;51(5):1200. doi: 10.18502/ijph.v51i5.9444.
3
In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.血管紧张素转换酶2（ACE2）的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）结合位点潜在抑制剂的单独或联合效应的计算机模拟比较
Iran J Public Health. 2021 May;50(5):1028-1036. doi: 10.18502/ijph.v50i5.6120.
4
The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.刺突蛋白-ACE2 结合分析：评估疫苗效力和筛选 SARS-CoV-2 抑制剂及中和抗体的体外平台。
J Immunol Methods. 2022 Apr;503:113244. doi: 10.1016/j.jim.2022.113244. Epub 2022 Feb 23.
5
Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.突变对人 SARS-CoV-2 受体结合域与宿主细胞受体 ACE2 结构、功能和动力学的影响：分子动力学模拟研究。
J Biomol Struct Dyn. 2021 Nov;39(18):7231-7245. doi: 10.1080/07391102.2020.1802348. Epub 2020 Aug 7.
6
Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.SARS-CoV-2 刺突受体结合域的突变景观和计算机结构模型揭示了病毒-宿主相互作用的关键分子决定因素。
BMC Mol Cell Biol. 2022 Jan 7;23(1):2. doi: 10.1186/s12860-021-00403-4.
7
Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的抑制剂筛选及其阻断病毒进入机制的能力：一项病毒信息学研究。
Saudi J Biol Sci. 2021 Jun;28(6):3262-3269. doi: 10.1016/j.sjbs.2021.02.066. Epub 2021 Feb 26.
8
In silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2.计算机模拟探索小分子 α-螺旋类似物作为 SARS-CoV-2 与 ACE2 结合抑制剂。
J Biomol Struct Dyn. 2022 Mar;40(4):1546-1557. doi: 10.1080/07391102.2020.1830175. Epub 2020 Oct 7.
9
Identification of potential inhibitors of SARS-CoV-2 S protein-ACE2 interaction by drug repurposing.通过药物再利用鉴定 SARS-CoV-2 S 蛋白与 ACE2 相互作用的潜在抑制剂。
F1000Res. 2021 May 7;10. doi: 10.12688/f1000research.52168.2. eCollection 2021.
10
Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction.基于结构的虚拟筛选及新型冠状病毒刺突蛋白受体结合域与血管紧张素转换酶2相互作用潜在抑制剂的鉴定
Front Chem. 2021 Sep 27;9:740702. doi: 10.3389/fchem.2021.740702. eCollection 2021.
本文引用的文献
1
COVID-19 Vaccine Booster: To Boost or Not to Boost.新冠疫苗加强针：打还是不打。
Infect Dis Rep. 2021 Oct 28;13(4):924-929. doi: 10.3390/idr13040084.
2
The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对 2019 冠状病毒病（COVID-19）临床结局的不同保护作用：系统评价和荟萃分析。
Ann Palliat Med. 2022 Apr;11(4):1253-1263. doi: 10.21037/apm-21-972. Epub 2021 Nov 4.
3
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey.秘鲁库斯科大流行期间用于 COVID-19 预防和呼吸道症状治疗的药用植物：一项横断面调查。
PLoS One. 2021 Sep 22;16(9):e0257165. doi: 10.1371/journal.pone.0257165. eCollection 2021.
4
In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.血管紧张素转换酶2（ACE2）的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）结合位点潜在抑制剂的单独或联合效应的计算机模拟比较
Iran J Public Health. 2021 May;50(5):1028-1036. doi: 10.18502/ijph.v50i5.6120.
5
Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies.调节血管紧张素转换酶2（ACE2）的天然产物作为潜在的COVID-19治疗方法。
Front Pharmacol. 2021 May 3;12:629935. doi: 10.3389/fphar.2021.629935. eCollection 2021.
6
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.血管紧张素-肾素-醛固酮系统抑制剂与 COVID-19 患者临床结局的相关性：系统评价和荟萃分析。
JAMA Netw Open. 2021 Mar 1;4(3):e213594. doi: 10.1001/jamanetworkopen.2021.3594.
7
An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2.传统波斯医学对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）管理的评估
Front Pharmacol. 2020 Nov 25;11:571434. doi: 10.3389/fphar.2020.571434. eCollection 2020.
8
A mathematical model for COVID-19 transmission dynamics with a case study of India.一个关于COVID-19传播动力学的数学模型及印度的案例研究。
Chaos Solitons Fractals. 2020 Nov;140:110173. doi: 10.1016/j.chaos.2020.110173. Epub 2020 Aug 5.
Zotero 插件